MTOR and hepatocellular carcinoma: Inspired by Zhou et al.’s research in hepatocellular carcinoma, our study further demonstrated enhanced phosphorylation of S6K1 and eIF4E induced by RPS4X activation, indicating the participation of the mTOR signaling pathway in this regulatory axis.